Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $28.19 for the day, up 1.70% from the previous closing price of $27.72. In other words, the price has increased by $1.70 from its previous closing price. On the day, 2.38 million shares were traded. VKTX stock price reached its highest trading level at $28.29 during the session, while it also had its lowest trading level at $27.59.
Ratios:
Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 44.25 and its Current Ratio is at 44.25. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $104.
On April 08, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $30.
On February 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $102.Scotiabank initiated its Sector Outperform rating on February 13, 2025, with a $102 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 03 ’25 when Lian Brian sold 26,889 shares for $27.80 per share. The transaction valued at 747,633 led to the insider holds 2,388,014 shares of the business.
ZANTE GREG sold 4,266 shares of VKTX for $118,428 on Jul 03 ’25. The Chief Financial Officer now owns 168,660 shares after completing the transaction at $27.76 per share. On Jul 03 ’25, another insider, Mancini Marianna, who serves as the Chief Operating Officer of the company, sold 4,266 shares for $27.77 each. As a result, the insider received 118,473 and left with 377,535 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 3166019072 and an Enterprise Value of 2125344896.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.65, which has changed by -0.44736326 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $81.73, while it has fallen to a 52-week low of $18.92. The 50-Day Moving Average of the stock is 3.20%, while the 200-Day Moving Average is calculated to be -29.27%.
Shares Statistics:
VKTX traded an average of 3.92M shares per day over the past three months and 4470050 shares per day over the past ten days. A total of 112.29M shares are outstanding, with a floating share count of 108.96M. Insiders hold about 2.96% of the company’s shares, while institutions hold 69.32% stake in the company. Shares short for VKTX as of 1749772800 were 28474422 with a Short Ratio of 7.26, compared to 1747267200 on 25543738. Therefore, it implies a Short% of Shares Outstanding of 28474422 and a Short% of Float of 30.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
